Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CAS?src=hash" target="_blank"gt;#CASlt;/agt;–According to Coherent Market Insights, the global CRISPR and CAS gene Market was valued at US$ 1,388.1…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that patient enrollment has been completed in the Phase 3 RESET (Rivipansel:…
Phase 3 drug candidate targeting molluscum SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the acquisition of economic rights to…
SL-279252 is the first Agonist Redirected Checkpoint molecule to enter clinical development from the Shattuck pipeline. AUSTIN, Texas–(BUSINESS WIRE)–Shattuck Labs,…
Dr. Brandt to Provide Translational Research Expertise and Clinical Support Advisory Services MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”),…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
NeuroPointDX Presents Further Data from Children’s Autism Metabolome Project at INSAR 2019 MADISON, Wis.–(BUSINESS WIRE)–Continued analysis of samples from the…
SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and…
MELBOURNE, Australia AND SAN FRANCISCO–(BUSINESS WIRE)–Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is today releasing interim…
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/SCI?src=hash" target="_blank"gt;#SCIlt;/agt;–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular…